Related Experiment Video
Updated: Jun 5, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Rethinking the diagnosis of von Willebrand disease
1Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, NSW, Australia. emmanuel.favaloro@swahs.health.nsw.gov.au
Insights
Von Willebrand disease (VWD) is a common inherited bleeding disorder caused by von Willebrand factor (VWF) issues. Diagnosis involves phenotypic assays, with newer methods enhancing VWD classification and management.
Area of Science:
- Hematology
- Clinical diagnostics
Background:
- Von Willebrand disease (VWD) is the most prevalent inherited bleeding disorder.
- It stems from deficiencies or defects in von Willebrand factor (VWF).
- VWD classification includes quantitative (Types 1 and 3) and qualitative (Type 2 variants) defects.
Purpose of the Study:
- To review the diagnostic process for VWD.
- To highlight newer diagnostic approaches and tools.
- To discuss the utility of desmopressin challenge data in diagnosis.
Main Methods:
- Phenotypic assays: FVIII, VWF:Ag, VWF activity (VWF:RCo, VWF:CB).
- Supplemental tests: multimer analysis, RIPA, VWF:FVIII binding.
- Consideration of genetic analysis in specific cases.
Main Results:
- Current classification relies on phenotypic assays.
- Extended test panels offer more comprehensive diagnostic information.
- Desmopressin challenge data is emerging as a valuable diagnostic aid.
Conclusions:
- Accurate VWD diagnosis and classification are crucial for patient management.
- Advancements in testing are refining diagnostic capabilities.
- Integrating novel approaches improves the diagnostic accuracy for VWD.
Abstract:
von Willebrand disease (VWD) is the most common inherited bleeding disorder and arises from deficiencies and/or defects in the plasma protein von Willebrand factor (VWF). VWD is classified into 6 different types, with type 1 identified as a (partial) quantitative deficiency of VWF, type 3 defined by a (virtual) total deficiency of VWF, and type 2 identifying four separate types (2A, 2B, 2M, 2N) characterised by qualitative defects. The classification is based on phenotypic assays including FVIII, VWF:Ag and VWF activity, typically by ristocetin cofactor (VWF:RCo), but also increasingly by collagen binding (VWF:CB). Phenotypic testing may be supplemented by multimer analysis, RIPA, and VWF:FVIII binding. Although genetic analysis is not required to diagnose VWD or to define a classification type, it may be useful in discrete situations. The current review briefly covers this diagnostic process, with a focus on newer approaches, including extended test panels and the use of data from desmopressin challenges as a diagnostic tool.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
